Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.
Marin F, Fernández MS, Lekuona I, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Freixa-Pamias R, Masjuan J, Pérez-Cabeza AI, Schilling VR, Vázquez Rodríguez JM, Priu CR, Sánchez MA. Marin F, et al. Among authors: lekuona i. J Comp Eff Res. 2022 Nov;11(16):1173-1184. doi: 10.2217/cer-2022-0111. Epub 2022 Sep 23. J Comp Eff Res. 2022. PMID: 36148923 Free article.
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study.
Sanmartín Fernández M, Anguita Sánchez M, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Esteve-Pastor MA, Freixa-Pamias R, Lekuona I, Pérez-Cabeza AI, Ureña I, Vázquez Rodríguez JM, Rafols Priu C, Marin F. Sanmartín Fernández M, et al. Among authors: lekuona i. Cardiol J. 2022;29(4):601-609. doi: 10.5603/CJ.a2022.0044. Epub 2022 May 27. Cardiol J. 2022. PMID: 35621092 Free PMC article.
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study.
Anguita Sánchez M, Marín F, Masjuan J, Cosín-Sales J, Vázquez Rodríguez JM, Barrios V, Barón-Esquivias G, Lekuona I, Pérez-Cabeza AI, Freixa-Pamias R, Parra Jimenez FJ, Monzer Khanji Khatib M, Rafols Priu C, Sanmartín Fernández M. Anguita Sánchez M, et al. Among authors: lekuona i. Cardiol J. 2022;29(6):936-947. doi: 10.5603/CJ.a2022.0091. Epub 2022 Oct 6. Cardiol J. 2022. PMID: 36200548 Free PMC article.
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry.
Rivera-Caravaca JM, Badimón L, Ferreira-Gonzalez I, Gómez-Doblas JJ, Roca-Luque I, Lekuona I, Jiménez-Candil J, Rodríguez-Padial L, González-Juanatey C, Calvo-Jambrina R, Fácila L, Ruiz-Ortiz M, Anguita M, Marín F. Rivera-Caravaca JM, et al. Among authors: lekuona i. Europace. 2022 Jan 4;24(1):4-11. doi: 10.1093/europace/euab131. Europace. 2022. PMID: 34115857
Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years.
Rodríguez-Mañero M, Bertomeu-González V, Cordero A, Moreno-Arribas J, Mazón P, Fácila L, Cosín J, Galve E, Lekuona I, González-Juanatey JR, Bertomeu-Martínez V. Rodríguez-Mañero M, et al. Among authors: lekuona i. Rev Port Cardiol. 2013 Feb;32(2):103-9. doi: 10.1016/j.repc.2012.06.011. Epub 2013 Jan 20. Rev Port Cardiol. 2013. PMID: 23337429 Free article.
Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction.
Fernández-Bergés D, Degano IR, Gonzalez Fernandez R, Subirana I, Vila J, Jiménez-Navarro M, Perez-Fernandez S, Roqué M, Bayes-Genis A, Fernandez-Aviles F, Mayorga A, Bertomeu-Gonzalez V, Sanchis J, Rodríguez Esteban M, Sanchez-Hidalgo A, Sanchez-Insa E, Elorriaga A, Abu Assi E, Nuñez A, Garcia Ruiz JM, Morrondo Valdeolmillos P, Bosch-Portell D, Lekuona I, Carrillo-Lopez A, Zamora A, Vega-Hernandez B, Alameda Serrano J, Rubert C, Ruiz-Valdepeñas L, Quintas L, Rodríguez-Padial L, Vaquero J, Martinez Dolz L, Barrabes JA, Sanchez PL, Sionis A, Martí-Almor J, Elosua R, Lidon RM, Garcia-Dorado D, Marrugat J; ATHOS investigators. Fernández-Bergés D, et al. Among authors: lekuona i. Open Heart. 2020 Aug;7(2):e001169. doi: 10.1136/openhrt-2019-001169. Open Heart. 2020. PMID: 32747454 Free PMC article.
Impact of new criteria for anticoagulant treatment in atrial fibrillation.
Rodríguez-Mañero M, Cordero A, Bertomeu-González V, Moreno-Arribas J, Bertomeu-Martínez V, Mazón P, Fácila L, Cosín J, Lekuona I, Galve E, González-Juanatey JR. Rodríguez-Mañero M, et al. Among authors: lekuona i. Rev Esp Cardiol. 2011 Aug;64(8):649-53. doi: 10.1016/j.recesp.2011.03.014. Epub 2011 Jun 8. Rev Esp Cardiol. 2011. PMID: 21652133 Free article. English, Spanish.
[Advances in arterial hypertension and diabetes mellitus].
Cordero A, Lekuona I, Galve E, Mazón P; Sección de Hipertensión Arterial, Grupo de Trabajo Corazón y Diabetes, Grupo de Trabajo Cardio-Renal, Sociedad Española de Cardiología, España. Cordero A, et al. Among authors: lekuona i. Rev Esp Cardiol (Engl Ed). 2012 Jan;65 Suppl 1:12-23. doi: 10.1016/j.recesp.2011.10.030. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22269836 Review. Spanish.
66 results